A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer’s disease

By sjmartinez • September 6, 2024

Sakimura K, Kawai T, Nashida R, Ishida Y, Harada K, Suzuki T, Okuma C, Cole GM. A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer's disease. Alzheimers Res Ther. 2024 Sep 5;16(1):197. doi: 10.1186/s13195-024-01552-2. PMID: 39238036.

Tags: 5xFAD, Aerobic glycolysis, Alzheimer’s disease, Geriatrics, Glucose metabolism, GRECC, PDH, PDHK, Publications, Pyruvate dehydrogenase, Pyruvate dehydrogenase kinase, Veterans Administration

In Vitro and In Vivo Evaluation of Small-Molecule Disassemblers of Pathological Tau Fibrils

Pan H, Cheng X, Zhang J, Hou K, Murray KA, Manglani K, Zhu C, Hsu HK, Mekkittikul M, Halladay T, Mirbaha H, Elezi G, Abskharon[...]

Cognitive Impairment Highly Prevalent and Associated With Reduced Physical Function in Older Veteran Clinical Exercise Program

Wilkins SS, Zhou JJ, Melrose RJ, Delgadillo M, Ogawa EF, Castle SC, Pearson M, Harris R, Wanagat J, Giffuni J, Alexander N, Gepner AD, Abbate[...]

Drug Development

Cole GM, Zhu C, Manglani K, Hou K, Bombino A, Jones M, Eisenberg DS, Frautschy SA. Drug Development. Alzheimers Dement. 2025 Dec;21 Suppl 5:e106249. doi:[...]